Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiding Chen

Showing results (111-120 of 133) with videos related to

Pageof 14
Sort By:
Breast Cancer Research and Treatment|December 3, 2013
Superior outcome after neoadjuvant chemotherapy with docetaxel, anthracycline, and cyclophosphamide versus docetaxel plus cyclophosphamide: results from the NATT trial in triple negative or HER2 positive breast cancerXiaosong Chen, Guolin Ye, Chenfang Zhang, et al.
Small (Weinheim an Der Bergstrasse, Germany)|January 25, 2026
Nanocomposite Cellulose Membranes for High-Performance Water Evaporation Electricity GenerationKelan Zhang, Liangpu Lv, Yiding Chen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 21, 2014
Serum profiling by mass spectrometry combined with bioinformatics for the biomarkers discovery in diffuse large B-cell lymphomaWenhong Xu, Yue Hu, Xuexin He, et al.
Molecular Cancer Research : MCR|September 6, 2022
HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer TumorigenesisJiahui Mou, Meijun Huang, Feifei Wang, et al.
Gastroenterology Report|June 22, 2026
Dysfunction of mitochondria in intestinal epithelial cells: a key player in the pathogenesis of inflammatory bowel diseasesJiangmei Pang, Mingshan Jiang, Yongbin Jia, et al.
Discovery Medicine|November 13, 2015
Study of distinct serum proteomics for the biomarkers discovery in colorectal cancerWenhong Xu, Yue Hu, Jun Li, et al.
Nature Communications|December 14, 2023
Pyrotinib plus docetaxel as first-line treatment for HER2-positive metastatic breast cancer: the PANDORA phase II trialYabing Zheng, Wen-Ming Cao, Xiying Shao, et al.
Journal of Cancer Research and Clinical Oncology|May 31, 2023
Postmastectomy radiotherapy in patients with T<sub>1-2</sub>N<sub>1</sub> breast cancer: a single center experience and a meta-analysisMeng Luo, Yao Jin, Chunjing Xu, et al.
Advances in Therapy|December 5, 2018
Patterns of Use of Docetaxel-Containing Adjuvant Chemotherapy Among Chinese Patients with Operable Breast Cancer: A Multicenter Observational StudyHui Xie, Jinping Liu, Shiyou Yu, et al.
International Journal of Oncology|September 18, 2020
Inhibition of DNA‑PK by gefitinib causes synergism between gefitinib and cisplatin in NSCLCChi Pan, Huijie Duan, Yinan Wu, et al.
Pageof 14

Showing results (111-120 of 133) with videos related to

Sort By:
Pageof 14
Breast Cancer Research and Treatment|December 3, 2013
Superior outcome after neoadjuvant chemotherapy with docetaxel, anthracycline, and cyclophosphamide versus docetaxel plus cyclophosphamide: results from the NATT trial in triple negative or HER2 positive breast cancerXiaosong Chen, Guolin Ye, Chenfang Zhang, et al.
Small (Weinheim an Der Bergstrasse, Germany)|January 25, 2026
Nanocomposite Cellulose Membranes for High-Performance Water Evaporation Electricity GenerationKelan Zhang, Liangpu Lv, Yiding Chen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 21, 2014
Serum profiling by mass spectrometry combined with bioinformatics for the biomarkers discovery in diffuse large B-cell lymphomaWenhong Xu, Yue Hu, Xuexin He, et al.
Molecular Cancer Research : MCR|September 6, 2022
HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer TumorigenesisJiahui Mou, Meijun Huang, Feifei Wang, et al.
Gastroenterology Report|June 22, 2026
Dysfunction of mitochondria in intestinal epithelial cells: a key player in the pathogenesis of inflammatory bowel diseasesJiangmei Pang, Mingshan Jiang, Yongbin Jia, et al.
Discovery Medicine|November 13, 2015
Study of distinct serum proteomics for the biomarkers discovery in colorectal cancerWenhong Xu, Yue Hu, Jun Li, et al.
Nature Communications|December 14, 2023
Pyrotinib plus docetaxel as first-line treatment for HER2-positive metastatic breast cancer: the PANDORA phase II trialYabing Zheng, Wen-Ming Cao, Xiying Shao, et al.
Journal of Cancer Research and Clinical Oncology|May 31, 2023
Postmastectomy radiotherapy in patients with T<sub>1-2</sub>N<sub>1</sub> breast cancer: a single center experience and a meta-analysisMeng Luo, Yao Jin, Chunjing Xu, et al.
Advances in Therapy|December 5, 2018
Patterns of Use of Docetaxel-Containing Adjuvant Chemotherapy Among Chinese Patients with Operable Breast Cancer: A Multicenter Observational StudyHui Xie, Jinping Liu, Shiyou Yu, et al.
International Journal of Oncology|September 18, 2020
Inhibition of DNA‑PK by gefitinib causes synergism between gefitinib and cisplatin in NSCLCChi Pan, Huijie Duan, Yinan Wu, et al.
Pageof 14